Journals / The Journal of Pediatric Research / 2018 / Cilt: 5 - Sayı: 1

Varicella-Related Hospitalizations Among Immunocompetent and Immunocompromised Children in Pre-Vaccine Era: A Tertiary Care Center Experience in Turkey

Pages
11–16
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since varicella virus vaccine prevents most of the morbidity and mortality caused by primary varicella in children, prevention rather than the treatment will be the optimal approach.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Although varicella is a common, contagious, self-limited childhood disease, it can cause significant long-term sequelae and mortality in both immunocompetent and immunocompromised children.
📊
Key Findings & Data:Results: Among 100 such children, 66 were immunocompetent and 34 were immunocompromised.
💡
Conclusion & Impact:Since varicella virus vaccine prevents most of the morbidity and mortality caused by primary varicella in children, prevention rather than the treatment will be the optimal approach.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Although varicella is a common, contagious, self-limited childhood disease, it can cause significant long-term sequelae and mortality in both immunocompetent and immunocompromised children. The aim of the present study is to identify and review varicella-related hospitalizations, admissions and complications of primary varicella infection among immunocompetent and immunocompromised children of a large unselected local population in a governmental institution.Materials and Methods: Demographic aspects, clinical features, microbiological findings, complications, managements and outcome of the patients hospitalized for varicella were analyzed retrospectively. Results: Among 100 such children, 66 were immunocompetent and 34 were immunocompromised. Secondary bacterial infection was the most common complication in both groups. The second most common complication in the immunocompetent group was neurological complications (21%) followed by varicella-zoster virus (VZV) pneumonia (2%). In the immunocompromised group neurological complications and VZV pneumonia were not observed. Hematological complications were seen in 5% of the immunocompetent patients and 6% of the immunocompromised patients. Mortality was seen in 2% in the study group, one patient in the immunocompetent and one in the immunocompromised group.Conclusion: Despite a common perception of varicella infection being highly contagious but harmless, complications requiring hospitalization are frequent, potentially serious and costly even in healthy children. Since varicella virus vaccine prevents most of the morbidity and mortality caused by primary varicella in children, prevention rather than the treatment will be the optimal approach.

🔖

Cite This Article

AKGÜN, Ö. D., TOPÇU, S., TANIR, N. G. (2018). Varicella-Related Hospitalizations Among Immunocompetent and Immunocompromised Children in Pre-Vaccine Era: A Tertiary Care Center Experience in Turkey. The Journal of Pediatric Research, Cilt: 5 - Sayı: 1, 11–16. https://ajindex.com/articles/362775

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Heininger U, Seward JF. Varicella. Lancet 2006;368:1365-76
  2. The Pink Book. Epidemiology and Prevention of VaccinePreventable Diseases. 13th ed. Course Textbook, 2015. p. 353-76
  3. Arvin AM. Varicella-zoster virus: molecular virology and virus-host interactions. Curr Opin Microbiol 2001;4:442-9
  4. Gershon AA. Varicella zoster virus In: Feigin RD, Cherry JD (eds). Textbook of Pediatric Infectious Diseases 4th ed. Philadelphia WB Saunders, 1998;1769-77
  5. Dinleyici EC, Kurugol Z, Turel O, et al. The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study). Eur J Pediatr 2012;171:817-25
  6. Jaeggi A, Zurbruegg RP, Aebi C. Complications of varicella in a defined central European population. Arch Dis Child 1998;79:472-7
  7. Peterson CL, Mascola L, Chao SM, et. al. Children hospitalized for varicella: a pre-vaccine review. J Pediatr 1996;129:529-36
  8. Koturoglu G, Kurugöl Z, Cetin N et al. Complications of varicella in healthy children in Izmir, Turkey. Pediatr Int 2005;47:296-9
  9. Theodoridou M, Laina I, Hadjichristodoulou C, Syriopoulou V. Varicella related complications and hospitalizations in tertiary pediatric medical centre before vaccine introduction. Eur J Pediatr 2006;165:273-4
  10. Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1- year survey. Pediatrics 2001;108:79
  11. Woods CR, Johnson CA. Varicella purpura fulminans associated with heterozygosity for factor V Leiden and transient protein C deficiency. Pediatrics 1998;102:1208-10
  12. Busuttil DP, Hay CR, Lewis MA, Wynn RF. Aggressive multiple modality therapy for varicella-associated purpura fulminans. Br J Hematol 2000;110:1012-3
  13. Amir A, Gilad O, Yacobovich J, Scheuerman O, Tamary H, Garty BZ. Post-varicella thrombocytopenic purpura. Acta Pediatr 2010;99:1385-8
  14. Bonhoeffer J, Baer G, Muehleisen B, et al. Prospective surveillance of hospitalizations associated with varicellazoster virus infections in children and adolescents. Eur J Pediatr 2005;164:366-70
  15. Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, v Kries R, et al. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J 2008;27:119-24
  16. Nguyen H, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccinat